Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
MDXG MiMedx
- 8.400
- +0.120+1.45%
Close Feb 14 16:00 ET
- 8.400
- 0.0000.00%
Post 20:01 ET
1.23BMarket Cap13.91P/E (TTM)
8.540High8.350Low379.10KVolume8.350Open8.280Pre Close3.19MTurnover0.35%Turnover Ratio22.70P/E (Static)146.95MShares10.14052wk High6.82P/B917.19MFloat Cap5.47052wk Low--Dividend TTM109.19MShs Float18.250Historical High--Div YieldTTM2.30%Amplitude0.309Historical Low8.424Avg Price1Lot Size
About MiMedx Company
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Company Profile
SymbolMDXG
Company NameMiMedx
Listing DateNov 4, 2020
Founded1985
CEOMr. Joseph H. Capper
MarketNASDAQ
Employees895
Fiscal Year Ends12-31
Address1775 West Oak Commons Court NE
CityMarietta
ProvinceGeorgia
CountryUnited States of America
Zip Code30062
Phone1-770-651-9100
Websitehttp://www.mimedx.com
Company Executives
- Name
- Position
- Salary
- Joseph H. Capper
- Director and Chief Executive Officer
- --
- Ricci S Whitlow
- Executive Vice President and Chief Operating Officer
- --
- William Frank Hulse, IV
- General Counsel and Chief Administrative Officer
- --
- Douglas C. Rice
- Chief Financial Officer and Chief Accounting Officer
- --
- Dr. M. Kathleen Behrens Wilsey, PhD
- Chairman of the Board
- --
- Dorothy E. Puhy
- Independent Director
- --
- K. Todd Newton
- Independent Director
- --
- James L. Bierman
- Independent Director
- --
- William A. Hawkins, III
- Independent Director
- --
- Tiffany P. Olson, M.B.A.
- Independent Director
- --
- Martin P. Sutter
- Independent Director
- --
- Dr. Cato T. Laurencin,M.D.,PhD
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.